Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Control ChangeItem 5.01 · 8-KMEDIUM RiskNeutral

Curis, Inc.

www.curis.com
Filed: Jun 25, 2026CIK: 0001108205Biotechnology
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Curis, Inc. stockholders approved a reverse stock split with a ratio between 1-for-5 and 1-for-25 at a special meeting on June 25, 2026, giving the Board discretion to implement the split to increase per-share price and maintain Nasdaq compliance.

Key Takeaways

Reverse stock split ratio authorized between 1-for-5 and 1-for-25, with final ratio to be determined by Board of Directors

Primary objectives are to increase per-share stock price and attract institutional investors

2 more takeaways

Filing Overview

Form Type8-K
Filing DateJun 25, 2026
Item5.01
CategoryControl Change
CIK0001108205
Accession #cris-20260625
Risk LevelMEDIUM
SentimentNeutral
Signalinformational
Topics
restructuring

What This Means

Control of the company has changed. This could be through acquisition, proxy contest, or board restructuring.
View Full Filing on SEC.govBrowse More Filings